CIK 0001177648
- Non-accelerated filer
- Smaller reporting company
ENANTA PHARMACEUTICALS INC
Sign in to watch- Ticker
- ENTA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Entity type
- Operating
- EIN
- 043205099
- Phone
- +1 617-607-0800
- Business address
- 4 KINGSBURY AVENUE, WATERTOWN, MA, 02472
- 4 Grant or award Chief Medical Officer acquired 7,000 shares (grant or award)
- 4 Grant or award Sr. VP & CSO acquired 21,000 shares (grant or award)
- 4 Grant or award Treasurer and CFO acquired 21,000 shares (grant or award)
- 4 Grant or award President and CEO acquired 63,000 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 20,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Option exercise Treasurer and CFO acquired 3,480 shares (option exercise)
- 4 Open-market sale Sr. VP & Chief Medical Officer sold 83,344 shares at an average $71.60 ($5,967,688)
- 4 Open-market sale Director sold 6,000 shares at an average $67.83 ($406,970)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Sr. VP & Chief Medical Officer sold 36,820 shares at an average $70.20 ($2,584,682)
- 4 Shares withheld for taxes Sr. VP, Business Dev. gave up 489 shares (to pay taxes)
- 4 Shares withheld for taxes Sr. VP, New Product Dev. gave up 552 shares (to pay taxes)
- 4 Shares withheld for taxes Sr. VP & General Counsel gave up 957 shares (to pay taxes)
- 4 Shares withheld for taxes Sr. VP & Chief Medical Officer gave up 954 shares (to pay taxes)
Page 8 of 24 · 475 filings